Addressing Fertility Information Needs and Distress
Launched by DUKE UNIVERSITY · Feb 18, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping female survivors of childhood cancer who are concerned about their fertility. The study aims to create and improve a program that provides information and support about fertility issues that may arise after cancer treatment. The goal is to help these women feel less anxious and more informed about their fertility status.
To participate in this trial, women need to be between the ages of 18 and 44, have been diagnosed with cancer before turning 18, and be unsure about their fertility status. Participants will not be recruited if they are currently receiving treatment from a fertility specialist or have serious mental health issues. The trial is still in the planning stages, so they are not recruiting participants yet. If eligible, women can expect to engage in a supportive program designed to address their specific fertility-related questions and concerns.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Currently aged 18-44
- • Diagnosed with cancer at \<18 years old
- • Female sex
- • Uncertain fertility status
- Exclusion Criteria:
- • Age \<18
- • Currently under the care of a fertility specialist
- • Having a major/serious psychiatric concern (e.g., schizophrenia) as indicated by medical chart/medical provider
- • Inability to provide consent.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported